NOTICE OF INTENT TO SOLE SOURCE - PROCUREMENT OF THE BIO-RAD CHEMIDOC MP IMAGING SYSTEM (PCA-NCI-09799)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL INSTITUTES OF HEALTH

Contract Value

Not provided

Codes & Classification
Solicitation Number

PCA-NCI-09799

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Classification Code

6525

Additional Details
Set Aside

NONE

Place of Performance

Bethesda, Maryland, UNITED STATES

SourceSAM
Documents1
The National Institutes of Health (NIH), specifically the National Cancer Institute (NCI), has issued a Special Notice of Intent to Sole Source for the procurement of a Bio-Rad ChemiDoc™ MP Imaging System (Procurement Identifier: PCA-NCI-09799). This notice, posted on September 25, 2026, is not a request for proposal but rather a pre-solicitation announcement indicating the agency’s intention to negotiate on an other-than-full-and-open competition basis with Bio-Rad Laboratories, Inc., located at 1000 Alfred Nobel Dr., Hercules, CA 94547-1811. The primary purpose of this procurement is to acquire a Bio-Rad ChemiDoc™ MP Imaging System that will integrate seamlessly with the NCI’s existing Bio-Rad Mini-Protean and Criterion electrophoresis systems. The intended outcome is to enhance the efficiency and capability of ongoing clinical pharmacology and translational research studies by ensuring compatibility and optimal workflow with current laboratory infrastructure. The ChemiDoc™ MP Imaging System is specifically required to support Bio-Rad Stain-Free workflows, which are integral to the NCI’s research operations. Key requirements for this procurement include: - The imaging system must be fully compatible with existing Bio-Rad electrophoresis equipment and workflows. - The solution must support Bio-Rad Stain-Free workflows, ensuring continuity and efficiency in laboratory processes. - The deliverable is the Bio-Rad ChemiDoc™ MP Imaging System, supplied by Bio-Rad Laboratories, Inc., the original developer and owner of the equipment. The procurement falls under NAICS Code 334516 (Analytical Laboratory Instrument Manufacturing), with Product Service Code 6525. The place of performance is Bethesda, Maryland, United States. There are no set-aside requirements for this procurement; it is open to all responsible sources, though the agency has determined that only Bio-Rad Laboratories, Inc. can meet the compatibility requirements at this time. While the NIH intends to proceed with a sole source award, interested vendors who believe they can provide a comparable product that meets the Government’s requirements are invited to submit a capabilities statement, including relevant past performance, to the contracting officer. Submissions must specifically address the challenge of integrating with existing Bio-Rad electrophoresis and Stain-Free workflows. All responses received by the closing date—12:00 pm Eastern Daylight Time, Wednesday, September 16, 2026—will be considered solely for the purpose of determining whether to conduct this procurement on a competitive basis. The Government reserves the right to make a final determination at its sole discretion. Questions or concerns regarding this notice should be directed in writing via email to Christine Biser, Contracting Officer, at [email protected]. The notice remains active and can be accessed via SAM.gov at https://sam.gov/opp/f7f46354ebd94e7aa34e8d62951dbc41/view. Contractors evaluating this opportunity should note the critical requirement for compatibility with existing Bio-Rad systems and workflows, as well as the sole source justification under 41 U.S.C. 3204(b)(2) and FAR 12.102(a). The procurement is managed by the Department of Health and Human Services, NIH, and will be performed in Bethesda, Maryland. No set-aside or special considerations apply beyond the technical requirements outlined above.